We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




FDA Approves First AI-Powered Radiation Exposure Reduction Solution

By HospiMedica International staff writers
Posted on 16 Apr 2019
An artificial intelligence (AI) powered region of interest (ROI) radiation exposure reduction solution for interventional X-ray imaging has received clearance from the US FDA. More...
The solution named FluoroShield has been developed by Omega Medical Imaging (Sanford, FL, USA) in conjunction with its technology partner IKOMED Technologies (Vancouver, BC Canada). Omega Medical Imaging designs, manufactures, delivers, and supports Interventional X-Ray Imaging devices for hospitals and healthcare facilities around the globe. IKOMED Technologies is a medical device company developing novel medical solutions based on proprietary technology.

FluoroShield is available only on Omega Medical Imaging’s Flat Panel detector CS-series product lines. It combines the power of AI, an ultra-fast collimator and the world’s most advanced image processing to deliver a ROI solution that has shown to reduce radiation exposure up to ~84%, seamlessly helping interventional clinicians to reach their ALARA goals. According to the company, the FluoroShield system utilizes AI to minimize X-ray dose to patients and staff, and uses TruBlock technology to completely block radiation. It delivers maximum radiation reduction, while optimizing workflow and achieves NextLevel image quality.

“FluoroShield is a critical piece of our innovation pipeline of solutions aimed at helping our partners deliver the best in patient outcomes and efficiencies,” said Brian Fleming, President of Omega Medical Imaging.

Related Links:
Omega Medical Imaging
IKOMED Technologies


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.